Is it just me, or is the market that CYC is targeting super small?
"Cyclopharm is initially targeting the 600,000 nuclear medicine imaging procedures for PE, a marketwhich it estimates to be approximately US$90 million per annum. Based on Cyclopharm’s experiencein the Canadian market and globally, the company reiterates expectations it can achieve a 50% shareof this market over the next 2 to 3 years, rising to in excess of an 80% share over a 3 to 5-year period."
Ann: Cyclopharm Receives USFDA Approval for Technegas, page-14
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.000(0.00%) |
Mkt cap ! $156.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9588 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 2800 | 1 |
View Market Depth
| Last trade - 16.12pm 06/11/2024 (20 minute delay) ? |
| CYC (ASX) Chart |
Day chart unavailable